EHR

Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities

Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…

8 months ago

Global Virtual Care Market to Surge: From $7.9 Billion in 2023 to $24.1 Billion by 2030 at a 19% CAGR | Valuates Reports

BANGALORE, India, April 25, 2025 /PRNewswire/ -- Virtual Care Market is Segmented by Type (Hospital-at-Home (HaH), Remote Therapeutic Monitoring (RTM),…

8 months ago

Global Virtual Care Market to Surge: From $7.9 Billion in 2023 to $24.1 Billion by 2030 at a 19% CAGR | Valuates Reports

BANGALORE, India, April 25, 2025 /PRNewswire/ -- Virtual Care Market is Segmented by Type (Hospital-at-Home (HaH), Remote Therapeutic Monitoring (RTM),…

8 months ago

North York General Becomes First Hospital in Canada to Migrate EHR to Oracle Cloud Infrastructure

OCI delivers improved performance and scalability to help increase efficiency and innovation  AUSTIN, Texas, April 25, 2025 /PRNewswire/ -- North…

8 months ago

North York General Becomes First Hospital in Canada to Migrate EHR to Oracle Cloud Infrastructure

OCI delivers improved performance and scalability to help increase efficiency and innovation  AUSTIN, Texas, April 25, 2025 /PRNewswire/ -- North…

8 months ago

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus…

8 months ago

ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma

- Data to be presented at AACR 2025 Annual Meeting suggest the combination of ALX Oncology’s investigational CD47-blocker, evorpacept, plus…

8 months ago

A Success Story – DelveInsight’s Strategic Support to a Biopharma Leader in NSCLC Epidemiology Forecasting up to 2034, Segmented by Biomarker Types

In the rapidly evolving landscape of oncology, precision is the cornerstone of progress. A leading biopharmaceutical company specializing in non-small…

8 months ago

Double Win for Workers’ Comp: Raintree Partners with Jopari and OccuPro to Transform Workers’ Comp

Raintree Helps Clinics Drive Revenue, Cut Manual Work, and Get Injured Workers Back on the Job Sooner CHANDLER, Ariz., April…

8 months ago

AmplifyMD Earns A+ in KLAS Emerging Company Spotlight Report

Healthcare leaders praise AmplifyMD's integrated virtual care platform for streamlining workflows, expanding clinical capacity, and driving operational efficiency LOS GATOS, Calif.,…

8 months ago